Skip to main content

Table 1 Baseline characteristics of patients

From: Predictors of secondary revascularization after coronary artery bypass graft surgery and role of dual antiplatelet therapy

Variable

AMT (N = 1,005)

DAPT (N = 1,458)

DAPT ≥ 6 months (N = 770)

p-value

Age (Years)

65.67 ± 10.02

64.71 ± 10.02

64.13 ± 9.94

0.019

Sex (Male, n)

761 (75.8%)

1,060 (72.7%)

526 (68.3%)

0.086

Race/Ethnicity (n)

   

0.282

Caucasian

885 (88.1%)

1,255 (86.1%)

639 (83.0%)

 

African American

32 (3.2%)

58 (4.0%)

42 (5.5%)

 

Native American

37 (3.7%)

67 (4.6%)

40 (5.2%)

 

Hispanic

25 (2.8%)

44 (3.0%)

30 (3.9%)

 

Asian

13 (1.3%)

18 (1.2%)

9 (1.2%)

 

Pacific Islander

1 (0.1%)

1 (0.1%)

0

 

Multiple

2 (0.2%)

9 (0.6%)

6 (0.8%)

 

Unknown

10 (1.0%)

6 (0.4%)

4 (0.5%)

 

BMI (Kg/m2)

30.63 ± 5.78

30.75 ± 5.98

30.83 ± 5.87

0.620

Smoker (n)

516 (51.4%)

816 (56.1%)

445 (57.8%)

0.478

Co-morbidities (n)

   

0.007

Hypertension

873 (86.9%)

1,268 (87.0%)

670 (87.0%)

0.941

CVA

70 (7.0%)

131 (9.0%)

80 (10.4%)

0.072

COPD

253 (25.2%)

393 (27.0%)

230 (27.2%)

0.323

Hyperlipidemia

707 (70.3%)

1,029 (70.6%)

533 (69.2%)

0.903

Diabetes Mellitus

423 (42.1%)

583 (40.0%)

332 (43.1%)

0.297

CKD

189 (18.8%)

205 (14.1%)

114 (14.8%)

0.002

MI

287 (28.6%)

461 (31.6%)

260 (33.8%)

0.104

Stable Angina

659 (65.6%)

884 (60.6%)

487 (63.2%)

0.013

CHF

215 (21.4%)

302 (20.7%)

169 (21.9%)

0.684

PAD

106 (10.5%)

216 (14.8%)

140 (18.2%)

0.002

HbA1c (%)

6.63 ± 1.52

6.61 ± 1.51

6.71 ± 1.57

0.773

GFR > 60 ml/min/1.73 m² (n)

705 (70.2%)

1,052 (72.6%)

546 (71.2%)

0.208

GFR < 60 ml/min/1.73 m² (Avg)

42.59 ± 13.80

44.98 ± 13.11

45.09 ± 12.68

0.020

Ejection Fraction (%)

52.29 ± 11.55

54.44 ± 11.98

52.41 ± 11.96

< 0.001

Previous PCI/Stent (n)

202 (20.1%)

357 (24.5%)

 

0.011

PCI

188 (18.7%)

329 (22.6%)

 

0.021

Stent

107 (10.6%)

194 (13.3%)

 

0.048